BBVA USA Bancshares’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | $6.68M | Sell |
14,122
-1,295
| -8% | -$613K | 0.32% | 85 |
|
2020
Q4 | $7.45M | Sell |
15,417
-2,366
| -13% | -$1.14M | 0.38% | 70 |
|
2020
Q3 | $10M | Sell |
17,783
-986
| -5% | -$554K | 0.57% | 38 |
|
2020
Q2 | $11.7M | Buy |
18,769
+92
| +0.5% | +$57.4K | 0.7% | 28 |
|
2020
Q1 | $9.12M | Buy |
18,677
+2,059
| +12% | +$1.01M | 0.65% | 33 |
|
2019
Q4 | $6.24M | Sell |
16,618
-759
| -4% | -$285K | 0.35% | 70 |
|
2019
Q3 | $4.82M | Buy |
17,377
+1,059
| +6% | +$294K | 0.31% | 90 |
|
2019
Q2 | $5.11M | Sell |
16,318
-87
| -0.5% | -$27.2K | 0.31% | 86 |
|
2019
Q1 | $6.74M | Buy |
16,405
+778
| +5% | +$319K | 0.42% | 59 |
|
2018
Q4 | $5.84M | Sell |
15,627
-60
| -0.4% | -$22.4K | 0.42% | 61 |
|
2018
Q3 | $6.34M | Buy |
15,687
+1,078
| +7% | +$436K | 0.38% | 67 |
|
2018
Q2 | $5.04M | Buy |
14,609
+3,490
| +31% | +$1.2M | 0.32% | 79 |
|
2018
Q1 | $3.83M | Sell |
11,119
-19
| -0.2% | -$6.54K | 0.25% | 97 |
|
2017
Q4 | $4.19M | Sell |
11,138
-2,401
| -18% | -$903K | 0.27% | 90 |
|
2017
Q3 | $6.05M | Sell |
13,539
-598
| -4% | -$267K | 0.4% | 62 |
|
2017
Q2 | $6.94M | Buy |
14,137
+795
| +6% | +$390K | 0.46% | 55 |
|
2017
Q1 | $5.17M | Buy |
13,342
+3,119
| +31% | +$1.21M | 0.35% | 72 |
|
2016
Q4 | $3.75M | Buy |
10,223
+5,911
| +137% | +$2.17M | 0.26% | 92 |
|
2016
Q3 | $1.73M | Buy |
+4,312
| New | +$1.73M | 0.13% | 162 |
|
2016
Q1 | – | Sell |
-707
| Closed | -$384K | – | 512 |
|
2015
Q4 | $384K | Buy |
707
+1
| +0.1% | +$543 | 0.03% | 374 |
|
2015
Q3 | $328K | Hold |
706
| – | – | 0.03% | 375 |
|
2015
Q2 | $360K | Hold |
706
| – | – | 0.02% | 403 |
|
2015
Q1 | $319K | Hold |
706
| – | – | 0.01% | 472 |
|
2014
Q4 | $290K | Buy |
706
+3
| +0.4% | +$1.23K | 0.01% | 480 |
|
2014
Q3 | $253K | Buy |
+703
| New | +$253K | 0.01% | 501 |
|
2014
Q2 | – | Sell |
-706
| Closed | -$212K | – | 556 |
|
2014
Q1 | $212K | Buy |
+706
| New | +$212K | 0.01% | 516 |
|